sarcopenia and glp 1 GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenic Obesity | Current Nutrition Reports Repurposing Drugs for Diabetes Mellitus
Description
Quick update on GLP-1 pricing
A recent Reuters investigation reveals that Chinese active pharmaceutical ingredient (API) suppliers, including Hybio Pharmaceutical and Jiangsu Sinopep-Allsino Biopharmaceutical, are pivoting to generic drug production
The trillion-dollar peptide
Struggling with a busy schedule, obesity, or type 2 diabetes
We review how it works.
No real change
/assets/images/provider/photos/2775923.jpeg)
